EVMN

EVOMMUNE INC

EVMN·30054Y107·US·Common Stock·Healthcare - Biotechnology-Activist

EVMN (EVOMMUNE INC) is held by 51 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($80.3M), RTW INVESTMENTS, LP ($34.5M), JPMORGAN CHASE & CO ($32.1M). Net institutional sentiment: Bullish.

51
Holders
Avg rating(9 Elite)
$353.2M
Total Value
79% (58)
Fund Consensus
45 buying - 12 selling
EVMNSmart Money Verdict
View all
Held by 51 funds
9 elite
Who's Trading
InsiderCKCarver KyleBuy $13KJul 8, 2026
InsiderDSDrew Janice SuzannSell $453KJun 22, 2026
InsiderPPPatel Jeegar PravinkumarSell $33KJun 22, 2026
InsiderPPPatel Jeegar PravinkumarSell $379KJun 1, 2026
ActivistL7LSP 7 Cooperatieve U.A.14.7%Feb 19, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.7%Feb 17, 2026
ActivistNFNan Fung Group Holdings Limited10.9%Feb 13, 2026
InsiderHLHopfner Robert LorneBuy $17KDec 19, 2025
ActivistANAndera Partners6.0%Nov 17, 2025
InsiderLULSP 7 Cooperative UABuy $25.0MNov 7, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.5M(+1.0%)$80.3M0.9%-24.88%
42
Increased
1.5M(+17.0%)$34.5M0.3%-28.38%
40
Increased
1.5M(+11.5%)$32.1M0.0%-27.32%
32
Increased
1.1M(+43.1%)$25.7M0.0%-32.03%
39
New
896,700$20.6M0.0%-44.68%
39
Decreased
879,728(-11.0%)$20.2M0.0%-24.60%
0
New
847,390$19.5M0.1%-44.68%
47
New
726,362$16.7M0.0%-44.68%
39
Increased
673,571(+372.9%)$15.5M0.0%-41.38%
45
Decreased
549,991(-2.7%)$12.6M0.1%-24.60%
0
Increased
492,938(+18.1%)$11.3M0.0%-28.57%
33
New
455,051$10.5M0.0%-44.68%
38
New
337,291$7.8M0.1%-44.68%
38
Unchanged
325,000$7.5M0.0%-24.60%
0
Increased
298,375(+8639.8%)$6.9M0.0%-44.51%
44
Increased
248,611(+126.5%)$5.7M0.0%-37.31%
44
Increased
179,511(+469.9%)$4.1M0.0%-41.97%
43
Increased
154,323(+150.2%)$3.5M0.0%-38.09%
43
Increased
94,948(+51.4%)$2.2M0.0%-32.88%
36
New
93,913$2.2M0.0%-44.68%
36

Showing 1-20 of 58

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used